Med tech stock Semler Scientific takes bitcoin play from MicroStrategy's book, surges 30%

在本文中

其他类型 缩水 追随你最喜欢的股票创建一个免费账户 罗伊特斯

塞姆勒科学, a little-known medical technology company, saw its shares surge on Tuesday after it said it has adopted 比特币 as its primary treasury reserve asset, taking a page out of MicroStrategy's playbook.

公司还宣布将以4亿美元的价格购买581个比特币,包括费用和费用.

据Coin Metrics显示,比特币交易量下跌了2%. 据Semler称,该公司的市值约为210亿美元,今年跌幅超过30%.

"我们的比特币财务策略和购买比特币强调了我们相信比特币是一个可靠的价值储备和一个有吸引力的投资", Semler科学公司主席Eric Semler在一份声明中说.

股票图标 股票图标 塞姆勒科学在宣布比特币财务战略后升

"我们认为,由于全球不稳定性,比特币具有独特的特征,作为一个稀缺且有限的资产,可以作为一个合理的通胀保护和安全避难所.

The move puts Semler in the same company as 微战略, which began employing an aggressive 比特币购买策略 in 2020 and has primarily traded as a proxy for the crypto's price since then. That stock is up about 163% this year.

微战略作为企业软件提供商推出. 今年2月,该公司表示将将其公司的重点和品牌转移到比特币开发.

塞姆勒周二表示,该公司将继续专注于其核心医疗产品和服务,

特斯拉 and 区块 are also among the companies that保持一些比特币on their balance sheets.

Bitcoin is up 60% this year and trading near its record. Many see adoption by corporate treasuries as a better 感觉采用指标, versus big-name funds holding and potentially trading the cryptocurrency.

然而,由于监管不确定性和ESG考虑因素,这一趋势尚未大幅度升级.

让我们一起看看CNBC PRO的故事:

现在投资者对以太子的问题 比特币价格可能在另一个五个月内不会重新测试今年的高点 摩根大通在加密货币上谨慎,